Compounds of formula (I), and pharmaceutically acceptable salts and esters thereof: (I); wherein Q, R2, X, Y and Z are as defined herein; are inhibitors of the hepatitis C virus (HCV) NS3 protease ##STR00001##
Web www.patentalert.com
< 3terminal sequence of hepatitis C virus genome and diagnostic and therapeutic uses thereof
< Ribonuclease resistant RNA preparation and utilization
> Sequences of hepatitis C virus genotypes and their use as prophylactic, therapeutic and diagnostic agents
> Highly sensitive gene detection and localization using in situ branched-DNA hybridization
HOME | NEW USER | LOGIN | SUBSCRIPTIONS | SEARCH | GUESTBOOK | CONTACT